ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.300
+0.010 (0.23%)
May 7, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.85 billion as of May 7, 2026. Its market cap has decreased by -12.93% in one year.
Market Cap
1.85B
Enterprise Value
972.83M
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.30
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.85B, a decrease of -74.59%. That is a compound annual growth rate of -40.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 1.86B | -26.24% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 2.78B |
| HighTide Therapeutics | 2.57B |
| Frontage Holdings | 1.99B |
| SinoMab BioScience | 1.98B |
| Mabpharm | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.72B |
| Beijing Biostar Pharmaceuticals | 1.71B |
| Cutia Therapeutics | 1.67B |